For some early stage lung cancer, new treatment options
At this stage Non-Small Cell Lung Cancer who can not accept surgical treatment, there are a very effective treatment options. Doctors said the choice of radical stereotactic radiosurgery with the Cyberknife treatment, patients treated more than three years for good lung power and 100% survival. "Our goal is to find a patient is unwilling or unable to be operative according to the rational choice," head of the study, said Dr. Brian Collins t Lombardi Comprehensive Cancer Center radiation oncologist at Georgetown University Hospital . "What we found is a very promising option that may be relevant to other phases of a patient. More to follow up these patients from the plan to see how they are 5 years after treatment, the progress made." An average follow-up of 36 months, overall survival for all patients was 79 in the 5 lung function decline as a result of death. The use of FEV1 in patients with a better survival rate 100%. The study was conducted by the digital navigation tool will be. Collins reports received from accuray, digital navigation tool for clinical consulting firm for compensation. Anderson has received honoraria accuray education.
More Common in Public Hospitals:Delays in Lung Cancer Care
The United States, a new study found that patients need to wait for diagnosis and treatment of lung cancer, the length of time by a number of health-care system factors. University of Texas Southwestern Medical Center researchers for analysis and diagnosis of 482 cases of non-small cell lung cancer data. They found that factors such as hospitals (private or public), insurance, age and race has its own time and the diagnosis of lung cancer patients receiving treatment to take a major impact.
Read more...
There is a risk, prophylactic cranial radiation therapy in patients with lung cancer
A new study has taken the benefits and risks of lung cancer, patients receiving a preventative brain radiation therapy to stopthe spread of cancer to the brain. The results showed that, although prophylactic cranial radiation in patients with non-small cell lung cancer (the most common form of lung cancer ), and reduces tumor metastasis to the brain the opportunity, but it affects a number of short-and long-term memory. Dr. Movsas will present the study results Nov. 2 at the plenary session for the 51st annual American Society for Radiation Oncology (ASTRO) meeting. Out of nearly 1,000 abstracts submitted, only a handful of study abstracts, including the one from Henry Ford, were selected for the ASTRO plenary session. The study was the National Radiation Oncology Group (RTOG) analysis of prophylactic cranial irradiation of patients with stage non-small cell lung cancer.
Read more...
A new method of treatment for lung cancer
The researchers Pier Paolo Scaglioni and Georgia Konstantinidou said that an experimental nature of the drug called BEZ235 with the combination of low-dose radiation successfully eliminated in mice with non-small cell lung cancer (NSCL). Dr. Scaglioni said: "These early results indicate that the drug combination of radiation may be able to effectively treat patients with lung cancer."
The researchers focus on joint development of mesothelioma drug
Mesothelioma patients may have received more than ever, a new drug for the treatment and prevention of this deadly cancer purposes. From China and the U.S. Drug researchers are co-receptors KDR / pack inhibitors, which would end the growth of cancer cells in patients. The two companies, the pioneer of China Pharmaceutical Group and OSI Pharmaceuticals in the United States, is based on Chinese projects. OSI, specializing in the discovery and innovative molecular targeted therapy development. The drug known as OSI, now 930, has been shown to small and treatment of non-small cell lung cancer, colon cancer, stomach cancer and other cancers of the positive results. It is in the treatment of these cancers the effectiveness of the team, as well as on its mesothelioma treatment. Mesothelioma, a rare form of lung cancer is determined by asbestos. Weight, until 1980 for the construction, shipbuilding, metal plates and other industrial undertakings, since asbestos has been found to be a dangerous mineral material, and has caused thousands of deaths. The material is used to make heat-resistant and flame retardant materials, and more durable. When these substances began to break down the asbestos fibers are released into the air, where they can easily breathe in. Once inside the human body, asbestos fibers were dependent on mesothelium, a membrane lining the lungs, heart and abdominal organs. This fiber can not be expelled, and they remain in the body and accumulate over time. Asbestos fibers interfere with cell development and operations, leading to mesothelioma, exposure for decades. If you find drug treatment or prevention of mesothelioma, it can provide new prospects for the nearly 3,000 new patients each year from the deadly disease of cancer pain.
Hispanic Americans are not easy to Cancer
This is the Spanish Heritage Month, a celebration of the fastest growing and largest minority in the United States. Hispanic Americans are less prone to cancer, according to the report released this week, the American Cancer Society. The researchers found that Hispanic Americans are more likely than non-Hispanic whites, development and death, including women, from a joint breast cancer, prostate cancer and colon and rectal cancer. However, this population may be, such as stomach, liver, and cervical infections, resulting in several types of cancer, high interest rates. The researchers also found that Hispanic cancer mortality were lower than non-Hispanic whites. More than 18,000 Hispanic Americans are expected to die of cancer this year, a year: in the top two Hispanic men between the cause of cancer deaths are lung cancer and colorectal cancer, while breast and lung cancer, is a Hispanic women's the top two. Association of Caribbean States wish to update the fact that the tumor-Hispanic documents to better understand cancer and to provide tools, they are better able to treat patients in Latin America.
60 inspiring miles to raise money for breast cancer research through Susan G. Komen for the Cure
by Joseph L. Wagner / Plain Dealer Reporter Lonnie Timmons III/The Plain Dealer Left to right, Lorie Marozzi, Debi Gilly, LaFond Ralston, Gina Ralston, Cathy Dowdy and cancer survivor Karen Cipriano cheer participants in the Cleveland Breast Cancer 3-Day on Saturday. The walk ends Sunday in Berea. BAY VILLAGE --Brenda Clawson-Flannagan rested Saturday at the halfway point of a three-day, 60-mile walk to raise money for breast cancer research and broke into laughter. "Am I supposed to feel this good?" she said. A good question considering that, in the past 16 months, she was diagnosed with breast cancer, finished eight rounds of chemotherapy and underwent a bilateral mastectomy, 35 rounds of radiation and 13 doses of milder cancer drugs. Her last treatment was a week ago. Not to mention the grueling trek that began Friday at the Port Authority docks in downtown Cleveland, wound its way through western suburbs and finishes Sunday afternoon at the Cuyahoga County Fairgrounds in Berea with closing ceremonies at 4:30 p.m. There were about 1,000 participants -- 200 fewer than last year, probably owing to the depressed economy. They pledged to raise $2,300 each with 85 percent of the donations going to the Susan G. Komen for the Cure fund. They raised money in their own unique ways, from a pink margaritas party to a youth hockey tournament. The final count for this weekend was not yet available, but the event raised $3.1 million last year. Clawson-Flannagan said her spirits were soaring, and why not? The marchers were rallied by exuberant Shaker Heights High School cheerleaders shouting, "Fight, fight, mighty walkers, fight." Torrie Knox, 15, a junior at the high school, and Sharae Murray, 15, a sophomore, both said they have aunts with breast cancer.
Read more...
Placenta Growth Factor & Mesothelioma Prognosis
Mesothelioma, like other cancers, grows and spreads through a process of angiogenesis, the growth of new blood vessels. Without a blood supply a mesothelioma tumor would starve and die. Vascular endothelial growth factor (VEGF) is a protein made by cells that stimulates new blood vessel formation. Therefore, treatments that slow or stop VEGF in tumors can slow or stop the formation of blood vessels ("anti-angiogenesis") and thereby halt the growth and spread of cancer. One type of VEGF is placenta growth factor (P1GF). A recent study investigated whether P1GF is over expressed in mesothelioma.1 If it is this could present a new therapeutic target. Specimens from twenty-seven patients with mesothelioma were compared with specimens from ten healthy patients. The researchers found that P1GF was not expressed in the normal mesothelium of the healthy subjects. However, it was over expressed in eleven (41%) of the patients with mesothelioma. In this study, the mean survival of the mesothelioma patients after extrapleural pneumonectomy (EPP) was 17 months, but the patients with the least P1GF expression survived the longest. In fact, no relationship was found between tumor stage and survival or between tumor stage and PIGF expression. This would suggest that P1GF plays a “pivotal role” in the recurrence and progression of mesothelioma after EPP.
Read more...
Elks Lodge displays car show for cancer research
By Trip Roberts Saturday, the Elks Lodge will be holding its seventh annual Charity Car, Truck and Motorcycle Show. Located at the Crawfordsville Elks Lodge on State Road 32 East and co-hosted by the Ben Hur Car Club, the show raises money for charitable donations to Indiana University and Purdue University for cancer research. The Elks Cancer Fund is a statewide effort that usually goes toward seed money for cancer research. With help from the Elks, smaller projects are able to attract big money.
Read more...
Tennis tournament serves as platform for cancer research fundraiser
By Sue Teggart C & G Sports Writer Junior tennis aces served up a new brand of tennis July 18, and while doing so raised awareness about a rare form of cancer. The Birmingham Athletic Club played host to the first Scott L. King Serving Aces for Sarcoma Quickstart tennis tournament, which set a record for the largest United States Tennis Association sanctioned-QuickStart event in the country. At the heart of the event was the goal of raising money for sarcoma research — a disease that claimed the life of King, a local tennis player, in June 2008. The event weekend ended up by raising over $70,000 — in combined individual donations and corporate sponsorships — for the University of Michigan Comprehensive Cancer Center. “Sarcoma is a rare disease, but the devastation is rapid,” said Susan Post, the event coordinator, adding that the rarity of the cancer and its subsequent lack of awareness makes it especially hard to raise funds for. “This year alone, it claimed 100,000 lives. So, it was amazing that we were able to raise so much money to impact future research.” King was remembered at the fundraiser as a successful executive in the automotive industry, a keen tennis competitor and as an advocate of introducing tennis to children. The QuickStart tournament was a fitting way to connect his love of the game and desire to familiarize children to the sport with fundraising for sarcoma. “We wanted to do something special, something different that would tie in one of Scott’s passions — the game of tennis — while also raising awareness about the need for funding sarcoma research,” BAC Director of Tennis Jeff Stassen said. “The QuickStart tournament was a perfect fit to honor our friend and continue his legacy in the tennis community.” QuickStart, which was established by USTA in 2008, is an exciting new format for learning tennis tailored for young players. It utilizes shorter racquets, smaller courts, smaller nets and lower-pressure balls. In all, 76 players competed in the boys and girls 8U and 10U divisions. There were 14 round-robin draws with four to six children per draw. Locally, 10-year-olds Hannah Reams and Luke Jorgenson, both of Bloomfield Hills, and James MacKenzie of Birmingham were winners. All players were acknowledged for being part of the largest QuickStart tournament recorded in the country. “The QuickStart format is a wonderful way to take down any obstacles that might face kids who want to get in the game,” Stassen said. “The equipment is quite inexpensive and can be played on a driveway or parking lot. With the scaled down equipment and slow bouncing ball, kids can start enjoying tennis very quickly.” The tournament field was made up of mostly local players, but in keeping with the spirit of QuickStart, 11 children — who were brought to the event by City of Detroit tennis coach and Think Detroit Police Athletic League Coaches Hall of Fame member Melvin Foreman — got their first taste of competitive tennis courtesy of the King Family Foundation.
|